Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Clinical trials sponsored by Suzhou Suncadia Biopharmaceuticals Co., Ltd., explained in plain language.
-
New hope for Tough-to-Treat lung cancer: major trial compares novel drug to standard chemo
Disease control OngoingThis large, late-stage study is comparing a new drug called SHR-A2009 to standard platinum-based chemotherapy. It's for adults with advanced or metastatic non-small cell lung cancer that has a specific genetic change (EGFR mutation) and has stopped responding to previous targeted…
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Apr 04, 2026 02:21 UTC
-
New drug cocktail aims to shrink tough stomach and esophageal tumors
Disease control OngoingThis study is testing a new three-drug combination for people with advanced stomach or esophageal cancer who haven't had prior treatment. It combines an experimental immunotherapy drug (SHR-8068) with an approved immunotherapy (adebrelimab) and standard chemotherapy. The main goa…
Phase: PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC